Overview

ZOE creates personalized nutrition plans through an at-home testing program and an AI-powered app. It analyzes an individual’s gut microbiome (via stool test), blood fats, and blood sugar responses (via a two-week continuous glucose monitor) to provide personalized food scores, recipes, and dietary recommendations. The model relies on large-scale nutrition science research (the PREDICT studies) and partnerships with leading institutions to tailor guidance to each person’s biology. Revenue comes from selling the test kit and a monthly subscription for app access, with an additional whole-food supplement (Daily30+). The company differentiates itself by combining gut microbiome data, metabolic responses, and AI for ongoing, data-driven personalization, backed by extensive nutrition science research. ZOE’s goal is to improve long-term health by helping people understand and act on their unique biological responses to food, effectively treating diet as personalized medicine.

Simplify's Take

What believers are saying

• $15M from Coefficient Capital funds US expansion post-May 2024 Nature Medicine trial.
• Free AI food camera app assesses processed food risk via photo or barcode instantly.
• Acquired Fascinate Productions to scale science-first podcast nutrition advice.

What critics are saying

• Levels Health captures US share with $199/year CGM versus ZOE's $60/month within 6-12 months.
• FDA recalls ZOE's unapproved CGM, stool kits after Viome fines halt US sales in 12-18 months.
• Noom's $10/month AI coaching with Abbott Libre CGM commoditizes ZOE advice in 12-24 months.

What makes ZOE unique

• PREDICT studies with King's College London, Harvard, Stanford analyze unique food responses.
• At-home kit tests gut microbiome, blood fat, continuous glucose for AI personalization.
• Published research in Nature Medicine, Lancet validates microbiome-driven nutrition advice.

Help us improve and share your feedback! Did you find this helpful?

YesNo